scispace - formally typeset
Open AccessJournal ArticleDOI

Pro-resolving lipid mediators are leads for resolution physiology

Charles N. Serhan
- 05 Jun 2014 - 
- Vol. 510, Iss: 7503, pp 92-101
Reads0
Chats0
TLDR
The mechanisms of specialized pro-resolving mediators and omega-3 essential fatty acid pathways that could help us to understand their physiological functions are covered.
Abstract
Advances in our understanding of the mechanisms that bring about the resolution of acute inflammation have uncovered a new genus of pro-resolving lipid mediators that include the lipoxin, resolvin, protectin and maresin families, collectively called specialized pro-resolving mediators. Synthetic versions of these mediators have potent bioactions when administered in vivo. In animal experiments, the mediators evoke anti-inflammatory and novel pro-resolving mechanisms, and enhance microbial clearance. Although they have been identified in inflammation resolution, specialized pro-resolving mediators are conserved structures that also function in host defence, pain, organ protection and tissue remodelling. This Review covers the mechanisms of specialized pro-resolving mediators and omega-3 essential fatty acid pathways that could help us to understand their physiological functions.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Receptors for pro-resolving mediators are increased in Alzheimer's disease brain.

TL;DR: BLT1 and ChemR23 receptors were detected in neurons and glial cells in all examined regions of the human brain, with markedly higher levels in AD than in controls, and receptor levels correlated with the density of staining for the inflammation markers HLA‐DR and YKL‐40 for microglia and astrocytes, respectively.
Journal ArticleDOI

A role for 12/15-lipoxygenase-derived proresolving mediators in postoperative ileus: protectin DX-regulated neutrophil extravasation.

TL;DR: Results show that 12/15‐lipoxygenase mediates postoperative ileus resolution via production of proresolving docosahexaenoic acid‐derived protectin DX.
Journal ArticleDOI

Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.

TL;DR: Proof of concept for local delivery of resolvin D1 to reduce inflammation and to improve the healing response after vein bypass grafting is provided and provides further support for the potential therapeutic role of specialized proresolving lipid mediators such as D‐series resolvins in modulating vascular injury and repair.
Journal ArticleDOI

Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents.

TL;DR: The main focus is placed on the comprehensive discussion of recently reported inhibitors of 5-LO, FLAP, LTA4 hydrolase and LTC4 synthase, based on literature search (PubMed and Thomson Innovation Patents Searches), covering 2012–2016.
Journal ArticleDOI

Vitamin D prenatal programming of childhood metabolomics profiles at age 3 y

TL;DR: The clusters differed in concentrations of inflammatory mediators, and cluster membership was influenced by in utero vitamin D exposure, suggesting a prenatal programming role of vitamin D on the child's metabolome.
References
More filters
Journal ArticleDOI

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

TL;DR: A better understanding of the molecular basis of myelomonocytic cell plasticity will open new vistas in immunopathology and therapeutic intervention and provide a paradigm for macrophage plasticity and function.
Journal ArticleDOI

Resolution of inflammation: the beginning programs the end.

TL;DR: Emerging evidence now suggests that an active, coordinated program of resolution initiates in the first few hours after an inflammatory response begins, and the mechanism required for inflammation resolution may underpin the development of drugs that can resolve inflammatory processes in directed and controlled ways.
Journal ArticleDOI

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

TL;DR: It is reported that lipidomic analysis of exudates obtained in the resolution phase from mice treated with ASA and docosahexaenoic acid produce a novel family of bioactive 17R-hydroxy-containing di- and tri-Hydroxy-docosanoids termed resolvins.
Journal ArticleDOI

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

TL;DR: Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained reduction in disease severity, including reversal of inflammation-mediated loss of sight, hearing and organ function.
Related Papers (5)